<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>
<channel>
	<title>Comments on: Medtech is never advanced if it doesn&#8217;t address cost</title>
	<atom:link href="http://mediligence.com/blog/2007/10/03/medtech-cost/feed/" rel="self" type="application/rss+xml" />
	<link>http://mediligence.com/blog/2007/10/03/medtech-cost/</link>
	<description>insights, perspectives and inside data from the founder of MMD</description>
	<pubDate>Wed, 07 Jan 2009 09:00:21 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: ZDNet Healthcare mobile edition</title>
		<link>http://mediligence.com/blog/2007/10/03/medtech-cost/comment-page-1/#comment-1519</link>
		<dc:creator>ZDNet Healthcare mobile edition</dc:creator>
		<pubDate>Thu, 04 Oct 2007 15:48:19 +0000</pubDate>
		<guid isPermaLink="false">http://mediligence.com/blog/2007/10/03/medtech-is-never-advanced-if-it-doesnt-address-cost/#comment-1519</guid>
		<description>[...] Medtech is never advanced if it doesn&#8217;t address costs, writes Patrick Driscol of MedMarket Intelligence,l who then goes on to explain how expensive laporascopies and stents are really cheap, when compared to their benefits. [...]</description>
		<content:encoded><![CDATA[<p>[...] Medtech is never advanced if it doesn&#8217;t address costs, writes Patrick Driscol of MedMarket Intelligence,l who then goes on to explain how expensive laporascopies and stents are really cheap, when compared to their benefits. [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
